New genetic test could identify 'high risk' bone marrow cancer patients
A new way of identifying high-risk bone marrow cancer may help predict which patients will have more aggressive disease...
Dr Christina Burke is a Volunteer Writer at BioNews, having originally joined under the auspices of its writing scheme. Christina now works for Quell Therapeutics in London. She has completed a PhD at the Institute of Child Health (based at University College London and at Great Ormond Street Hospital for Children. There, her research focused on new therapies for the treatment of childhood cancers. She originally studied Natural Sciences at the University of Cambridge, and went on to obtain an MSc in Drug Discovery and Development at UCL's School of Pharmacy. She has also completed placements in HIV research and at the biotechnology company Immunocore, and she has worked at the World Health Organisation Antimicrobial Resistance Secretariat.
A new way of identifying high-risk bone marrow cancer may help predict which patients will have more aggressive disease...
'What is it to be human? What is it to be family?' These are the words of this week's interviewee, Jack Nunn, on The Genetics Society 'Unzipped' podcast: 'Hidden family secrets unveiled by genetic testing'...
The UK government has launched a public consultation on whether to change the ten-year storage limit on frozen eggs, sperm, and embryos...
Results published from a pioneering clinical trial in the USA have confirmed for the first time that treatment with genome-edited cells appears safe...
Next-generation DNA sequencing is helping to rapidly identify and characterise the coronavirus at the centre of the recent outbreak...
Researchers have discovered a new mechanism of DNA transcription regulation, controlled by specialised subtypes of RNA molecules...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.